Catheter Dysfunction: The Role of Lock Solutions

Seminars in Dialysis

Volumn 25, Issue 6, 2012, Pages 693-699

  Niyyar, Vandana Dua ^a  

^a EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTEREMIA; CATHETER INFECTION; CENTRAL VENOUS CATHETERIZATION; HUMAN; INDWELLING CATHETER; RENAL REPLACEMENT THERAPY; REVIEW; SOLUTION AND SOLUBILITY; THROMBOSIS;

BACTEREMIA; CATHETER-RELATED INFECTIONS; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; HUMANS; RENAL DIALYSIS; SOLUTIONS; THROMBOSIS;

EID: 84870052826     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/j.1525-139X.2011.00991.x     Document Type: Review

References (72)

1. U.S. Renal Data System: USRDS 2010 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2010.
2. K-DOQI: Clinical practice guidelines for vascular access. Am J Kidney Dis 48(Suppl 1):S176-S247, 2006.
3. Fistula First National Vascular Access Improvement Initiative, 2010. Available at http//www.fistulafirst.org.
4. Chan MR, Sanchez RJ, Young HN, Yevzlin AS: Vascular access outcomes in the elderly hemodialysis population: a USRDS study. Semin Dial 20:606-610, 2007.
5. Ash SR: Advances in tunneled central venous catheters for dialysis: design and performance. Semin Dial 21:504-515, 2008.
6. Saad TF: Bacteremia associated with tunneled, cuffed hemodialysis catheters. Am J Kidney Dis 34:1114-1124, 1999.
7. Beathard GA: Dysfunction of new catheters by old fibrin sheaths. Semin Dial 17:243-244, 2004.
8. Oliver MJ, Mendelssohn DC, Quinn RR, Richardson EP, Rajan DK, Pugash RA, Hiller JA, Kiss AJ, Lok CE: Catheter patency and function after catheter sheath disruption: a pilot study. Clin J Am Soc Nephrol. 2:1201-1206, 2007.
9. Little MA, O'Riordan A, Lucey B, Farrell M, Lee M, Conlon PJ, Walshe JJ: A prospective study of complications associated with cuffed, tunnelled haemodialysis catheters. Nephrol Dial Transplant 16:2194-2200, 2001.
10. Dasgupta MK: Biofilms and infection in dialysis patients. Semin Dial 15:338-346, 2002.
11. van Rooden CJ, Schippers EF, Barge RM, Rosendaal FR, Guiot HF, van der Meer FJ, Meinders AE, Huisman MV: Infectious complications of central venous catheters increase the risk of catheter-related thrombosis in hematology patients: a prospective study. J Clin Oncol 23:2655-2660, 2005.
12. Mehall JR, Saltzman DA, Jackson RJ, Smith SD: Fibrin sheath enhances central venous catheter infection. Crit Care Med 30:908-912, 2002.
13. Beathard GA: Management of bacteremia associated with tunneled-cuffed hemodialysis catheters. J Am Soc Nephrol 10:1045-1049, 1999.
14. Maya ID: Antibiotic lock for treatment of tunneled hemodialysis catheter bacteremia. Semin Dial 21:539-541, 2008.
15. Shanks RM, Sargent JL, Martinez RM, Graber ML, O'Toole GA: Catheter lock solutions influence staphylococcal biofilm formation on abiotic surfaces. Nephrol Dial Transplant 21:2247-2255, 2006.
16. Shanks RM, Donegan NP, Graber ML, Buckingham SE, Zegans ME, Cheung AL, O'Toole GA: Heparin stimulates Staphylococcus aureus biofilm formation. Infect Immun 73:4596-4606, 2005.
17. Weijmer MC, Debets-Ossenkopp YJ, Van De Vondervoort FJ, ter Wee PM: Superior antimicrobial activity of trisodium citrate over heparin for catheter locking. Nephrol Dial Transplant 17:2189-2195, 2002.
18. Jones SM, Ravani P, Hemmelgarn BR, Muruve D, Macrae JM: Morphometric and biological characterization of biofilm in tunneled hemodialysis catheters. Am J Kidney Dis 57:449-455, 2011.
19. Allon M: Prophylaxis against dialysis catheter-related bacteremia with a novel antimicrobial lock solution. Clin Infect Dis 36:1539-1544, 2003.
20. Landry DL, Braden GL, Gobeille SL, Haessler SD, Vaidya CK, Sweet SJ: Emergence of gentamicin-resistant bacteremia in hemodialysis patients receiving gentamicin lock catheter prophylaxis. Clin J Am Soc Nephrol. 5:1799-1804, 2010.
21. Dogra GK, Herson H, Hutchison B, Irish AB, Heath CH, Golledge C, Luxton G, Moody H: Prevention of tunneled hemodialysis catheter-related infections using catheter-restricted filling with gentamicin and citrate: a randomized controlled study. J Am Soc Nephrol 13:2133-2139, 2002.
22. Jaffer Y, Selby NM, Taal MW, Fluck RJ, McIntyre CW: A meta-analysis of hemodialysis catheter locking solutions in the prevention of catheter-related infection. Am J Kidney Dis 51:233-241, 2008.
23. Weijmer MC, van den Dorpel MA, Van de Ven PJ, ter Wee PM, van Geelen JA, Groeneveld JO, van Jaarsveld BC, Koopmans MG, le Poole CY, Schrander-Van der Meer AM, Siegert CEH, Stas KJF; for the CITRATE Study Group: Randomized, clinical trial comparison of trisodium citrate 30% and heparin as catheter-locking solution in hemodialysis patients. J Am Soc Nephrol 16:2769-2777, 2005.
24. Betjes MG, van Agteren M: Prevention of dialysis catheter-related sepsis with a citrate-taurolidine-containing lock solution. Nephrol Dial Transplant 19:1546-1551, 2004.
25. Kim SH, Song KI, Chang JW, Kim SB, Sung SA, Jo SK, Cho WY, Kim HK: Prevention of uncuffed hemodialysis catheter-related bacteremia using an antibiotic lock technique: a prospective, randomized clinical trial. Kidney Int 69:161-164, 2006.
26. McIntyre CW, Hulme LJ, Taal M, Fluck RJ: Locking of tunneled hemodialysis catheters with gentamicin and heparin. Kidney Int 66:801-805, 2004.
27. Nori US, Manoharan A, Yee J, Besarab A: Comparison of low-dose gentamicin with minocycline as catheter lock solutions in the prevention of catheter-related bacteremia. Am J Kidney Dis 48:596-605, 2006.
28. Saxena AK, Panhotra BR, Sundaram DS, Morsy MN, Al-Ghamdi AM: Enhancing the survival of tunneled haemodialysis catheters using an antibiotic lock in the elderly: a randomised, double-blind clinical trial. Nephrology (Carlton) 11:299-305, 2006.
29. Allon M: Prophylaxis against dialysis catheter-related bacteremia: a glimmer of hope. Am J Kidney Dis 51:165-168, 2008.
30. Bleyer AJ, Mason L, Russell G, Raad II, Sherertz RJ: A randomized, controlled trial of a new vascular catheter flush solution (minocycline-EDTA) in temporary hemodialysis access. Infect Control Hosp Epidemiol 26:520-524, 2005.
31. Bleyer AJ: Use of antimicrobial catheter lock solutions to prevent catheter-related bacteremia. Clin J Am Soc Nephrol 2:1073-1078, 2007.
32. Steczko J, Ash SR, Nivens DE, Brewer L, Winger RK: Microbial inactivation properties of a new antimicrobial/antithrombotic catheter lock solution (citrate/methylene blue/parabens). Nephrol Dial Transplant 24:1937-1945, 2009.
33. Sauer K, Steczko J, Ash SR: Effect of a solution containing citrate/methylene blue/parabens on Staphylococcus aureus bacteria and biofilm, and comparison with various heparin solutions. J Antimicrob Chemother 63:937-945, 2009.
34. Krishnasami Z, Carlton D, Bimbo L, Taylor ME, Balkovetz DF, Barker J, Allon M: Management of hemodialysis catheter-related bacteremia with an adjunctive antibiotic lock solution. Kidney Int 61:1136-1142, 2002.
35. Vardhan A, Davies J, Daryanani I, Crowe A, McClelland P: Treatment of haemodialysis catheter-related infections. Nephrol Dial Transplant 17:1149-1150, 2002.
36. Poole CV, Carlton D, Bimbo L, Allon M: Treatment of catheter-related bacteraemia with an antibiotic lock protocol: effect of bacterial pathogen. Nephrol Dial Transplant 19:1237-1244, 2004.
37. Maya ID, Carlton D, Estrada E, Allon M: Treatment of dialysis catheter-related Staphylococcus aureus bacteremia with an antibiotic lock: a quality improvement report. Am J Kidney Dis 50:289-295, 2007.
38. Peterson WJ, Maya ID, Carlton D, Estrada E, Allon M: Treatment of dialysis catheter-related Enterococcus bacteremia with an antibiotic lock: a quality improvement report. Am J Kidney Dis 53:107-111, 2009.
39. Fernandez-Hidalgo N, Almirante B, Calleja R, Ruiz I, Planes AM, Rodriguez D, Pigrau C, Pahissa A: Antibiotic-lock therapy for long-term intravascular catheter-related bacteraemia: results of an open, non-comparative study. J Antimicrob Chemother 57:1172-1180, 2006.
40. Bregman H: Double lumen subclavian hemodialysis cannulas. Int J Artif Organs 8:17-18, 1985.
41. Snider HC, Ingalls CE, Schloeder FX, Sivanna P: Use of subclavian catheters for hemodialysis. South Med J 75:1093-1094, 1982.
42. Ash SR: Fluid mechanics and clinical success of central venous catheters for dialysis-answers to simple but persisting problems. Semin Dial 20:237-256, 2007.
43. Xiang DZ, Verbeken EK, Van Lommel AT, Stas M, De Wever I: Composition and formation of the sleeve enveloping a central venous catheter. J Vasc Surg 28:260-271, 1998.
44. Trerotola SO, Kraus M, Shah H, Namyslowski J, Johnson MS, Stecker MS, Ahmad I, Mclennan G, Patel NH, O'Brien E, Lane KA, Ambrosius WT: Randomized comparison of split tip versus step tip high-flow hemodialysis catheters. Kidney Int 62:282-289, 2002.
45. Tal MG: Comparison of recirculation percentage of the palindrome catheter and standard hemodialysis catheters in a swine model. J Vasc Interv Radiol 16:1237-1240, 2005.
46. Hirsh J, Anand SS, Halperin JL, Fuster V: AHA Scientific Statement: guide to anticoagulant therapy: heparin: a statement for healthcare professionals from the American Heart Association. Arterioscler Thromb Vasc Biol 21:E9-E33, 2001.
47. Karaaslan H, Peyronnet P, Benevent D, Lagarde C, Rince M, Leroux-Robert C: Risk of heparin lock-related bleeding when using indwelling venous catheter in haemodialysis. Nephrol Dial Transplant 16:2072-2074, 2001.
48. Yevzlin AS, Sanchez RJ, Hiatt JG, Washington MH, Wakeen M, Hofmann RM, Becker YT: Concentrated heparin lock is associated with major bleeding complications after tunneled hemodialysis catheter placement. Semin Dial 20:351-354, 2007.
49. Sungur M, Eryuksel E, Yavas S, Bihorac A, Layon AJ, Caruso L: Exit of catheter lock solutions from double lumen acute haemodialysis catheters-an in vitro study. Nephrol Dial Transplant 22:3533-3537, 2007.
50. Thomas CM, Zhang J, Lim TH, Scott-Douglas N, Hons RB, Hemmelgarn BR: Concentration of heparin-locking solution and risk of central venous hemodialysis catheter malfunction. ASAIO J 53:485-488, 2007.
51. Holley JL, Bailey S: Catheter lock heparin concentration: effects on tissue plasminogen activator use in tunneled cuffed catheters. Hemodial Int 11:96-98, 2007.
52. Ivan DM, Smith T, Allon M: Does the heparin lock concentration affect hemodialysis catheter patency? Clin J Am Soc Nephrol 5:1458-1462, 2010.
53. Moran JE, Ash SR: Locking solutions for hemodialysis catheters; heparin and citrate-a position paper by ASDIN. Semin Dial 21:490-492, 2008.
54. Blossom DB, Kallen AJ, Patel PR, Elward A, Robinson L, Gao G, Langer R, Perkins KM, Jaeger JL, Kurkjian KM, Jones M, Schillie SF, Shehab N, Ketterer D, Venkataraman G, Kishimoto TK, Shriver Z, McMahon AW, Austen KF, Kozlowski S, Srinivasan A, Turabelidze G, Gould CV, Arduino MJ, Sasisekharan R: Outbreak of adverse reactions associated with contaminated heparin. N Engl J Med 359:2674-2684, 2008.
55. Macrae JM, Dojcinovic I, Djurdjev O, Jung B, Shalansky S, Levin A, Kiaii M: Citrate 4% versus heparin and the reduction of thrombosis study (CHARTS). Clin J Am Soc Nephrol 3:369-374, 2008.
56. Grudzinski L, Quinan P, Kwok S, Pierratos A: Sodium citrate 4% locking solution for central venous dialysis catheters-an effective, more cost-efficient alternative to heparin. Nephrol Dial Transplant 22:471-476, 2007.
57. Lok CE, Appleton D, Bhola C, Khoo B, Richardson RM: Trisodium citrate 4%-an alternative to heparin capping of haemodialysis catheters. Nephrol Dial Transplant 22:477-483, 2007.
58. Buturovic J, Ponikvar R, Kandus A, Boh M, Klinkmann J, Ivanovich P: Filling hemodialysis catheters in the interdialytic period: heparin versus citrate versus polygeline: a prospective randomized study. Artif Organs 22:945-947, 1998.
59. Polaschegg HD, Sodemann K: Risks related to catheter locking solutions containing concentrated citrate. Nephrol Dial Transplant 18:2688-2690, 2003.
60. FDA. Cited 30 September 2010. Available at http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm173095.htm.
61. Schenk P, Rosenkranz AR, Wolfl G, Horl WH, Traindl O: Recombinant tissue plasminogen activator is a useful alternative to heparin in priming quinton permcath. Am J Kidney Dis 35:130-136, 2000.
62. Mokrzycki MH, Jean-Jerome K, Rush H, Zdunek MP, Rosenberg SO: A randomized trial of minidose warfarin for the prevention of late malfunction in tunneled, cuffed hemodialysis catheters. Kidney Int 59:1935-1942, 2001.
63. Traynor JP, Walbaum D, Woo YM, Teenan P, Fox JG, Mactier RA: Low-dose warfarin fails to prolong survival of dual lumen venous dialysis catheters. Nephrol Dial Transplant 16:645, 2001.
64. Hemmelgarn BR, Moist LM, Lok CE, Tonelli M, Manns BJ, Holden RM, LeBlanc M, Faris P, Barre P, Zhang J, Scott-Douglas N; for the Prevention of Dialysis Catheter Lumen Occlusion with rt-PA versus Heparin (PreCLOT) Study Group: Prevention of dialysis catheter malfunction with recombinant tissue plasminogen activator. N Engl J Med 64:303-312, 2011.
65. Paulsen D, Reisoether A, Aasen M, Fauchald P: Use of tissue plasminogen activator for reopening of clotted dialysis catheters. Nephron 64:468-470, 1993.
66. Falk A, Samson W, Uribarri J, Vassalotti JA: Efficacy of reteplase in poorly functioning hemodialysis catheters. Clin Nephrol 61:47-53, 2004.
67. Macrae JM, Loh G, Djurdjev O, Shalansky S, Werb R, Levin A, Kiaii M: Short and long alteplase dwells in dysfunctional hemodialysis catheters. Hemodial Int 9:189-195, 2005.
68. Webb A, Abdalla M, Russell GI: A protocol of urokinase infusion and warfarin for the management of the thrombosed haemodialysis catheter. Nephrol Dial Transplant 16:2075-2078, 2001.
69. Savader SJ, Ehrman KO, Porter DJ, Haikal LC, Oteham AC: Treatment of hemodialysis catheter-associated fibrin sheaths by rt-PA infusion: critical analysis of 124 procedures. J Vasc Interv Radiol 12:711-715, 2001.
70. Hilleman DE, Dunlay RW, Packard KA: Reteplase for dysfunctional hemodialysis catheter clearance. Pharmacotherapy 23:137-141, 2003.
71. Little MA, Walshe JJ: A longitudinal study of the repeated use of alteplase as therapy for tunneled hemodialysis catheter dysfunction. Am J Kidney Dis 39:86-91, 2002.
72. Ash S: Catheter locks for central vein catheters for dialysis. Davita Quest 14:18-24, 2008.